Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related SRPT
Drug Trial Extension By FDA Doesn't Change Baird's Outlook On Sarepta
Jim Cramer Tries To Limit Risk On Ionis Pharmaceuticals And Sarepta Therapeutics
Related PCS
Is Wireless The New Cable?
Morgan Stanley Says Sprint's Headline EBITDA Should Be Strong

Sarepta Therapeutics (NASDAQ: SRPT) surged 133.56% to $35.01 in the pre-market session. Sarepta Therapeutics reported that treatment with its eteplirsen met its primary endpoint in a Phase IIb extension trial in Duchenne muscular dystrophy patients.

MetroPCS Communications (NYSE: PCS) added 6.85% to $14.50 in the pre-market session. MetroPCS board has approved merger with Deutsche Telekom's T-Mobile USA unit, according to German newspaper Financial Times Deutschland.

Best Buy Co (NYSE: BBY) moved up 3.01% to $17.48 in the pre-market session. Best Buy shares have dropped 26.73% over the past 52 weeks, while the S&P 500 index has gained 28.63% in the same period.

Family Dollar Stores (NYSE: FDO) soared 2.27% to $67.50 in the pre-market trading. Family Dollar reported a rise in its fiscal fourth-quarter profit.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (BBY + FDO)

View Comments and Join the Discussion!